Showing results (61-70 of 472) with videos related to

Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|December 15, 2023
The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosisChun Shing Kwok, William E Moody
Therapeutic Advances in Cardiovascular Disease|December 9, 2023
A comprehensive review of the novel therapeutic targets for the treatment of diabetic cardiomyopathyArti Dhar, Jegadheeswari Venkadakrishnan, Utsa Roy, et al.
Therapeutic Advances in Cardiovascular Disease|September 19, 2023
Transient left bundle branch block associated with very high coronary artery calcium: a case reportAlexander C Razavi, Sindhu Prabakaran, Mariem Sawan, et al.
Therapeutic Advances in Cardiovascular Disease|September 21, 2023
Neointimal characteristic changes following drug-coated balloons in lesions with repeated revascularizationYosuke Takei, Hiroyoshi Mori, Takahiro Tezuka, et al.
Therapeutic Advances in Cardiovascular Disease|March 13, 2018
Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic diseaseCarmen Gonzalez-Hidalgo, Joaquin De Haro, Silvia Bleda, et al.
Therapeutic Advances in Cardiovascular Disease|March 19, 2020
Multicap to improve adherence after acute coronary syndromes: results of a randomized controlled clinical trialJavier Mariani, Andrés Rosende, Maximiliano De Abreu, et al.
Therapeutic Advances in Cardiovascular Disease|July 25, 2022
Polypharmacy among older individuals with heart failure: trends between 2000 and 2017 in the province of Quebec, CanadaAlexandre Campeau Calfat, Marc Simard, Amina Ouali, et al.
Therapeutic Advances in Cardiovascular Disease|December 25, 2015
The potential cost-effectiveness of the Diamondback 360® Coronary Orbital Atherectomy System for treating de novo, severely calcified coronary lesions: an economic modeling approachJeffrey Chambers, Philippe Généreux, Arthur Lee, et al.
Therapeutic Advances in Cardiovascular Disease|February 10, 2016
Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registryHamid Reza Poorhoseini, Seyed Ebrahim Kassaian, Kianoosh Hoseini, et al.
Therapeutic Advances in Cardiovascular Disease|February 13, 2016
Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damageMd Quamrul Hassan, Md Sayeed Akhtar, Mohd Akhtar, et al.
Pageof 48